Most firms face a challenge of improving returns on investment in pharma R&D. Hasini Wijesuriya explains how they can achieve enhanced R&D efficiency.
Dr. Hasini Wijesuriya, Associate Director and Engagement Manager, Life Sciences Strategy Group and Prof. Hilary Thomas, Chief Medical Adviser, explains that new ways of understanding patients, their behaviour and their optimum outcomes might unlock a new era of R&D efficiency:
Find out more details by downloading our insight exploring the opportunities for efficiency in R&D.
© 2020 KPMG LLP a UK limited liability partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.